课题基金 / 基金详情

MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS

MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
IHSS 患者恶性室性心律失常的治疗
批准号：
3874325
负责人：
L FANANAPAZIR
金额：
$0.0万
依托单位：
CLINICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3874325
关键词：
disease /disorder proneness /risk drug metabolism electrophysiology ganglionic blocking agents heart disorder chemotherapy heart electrical activity heart pharmacology human subject hypertrophic myocardiopathy myocardium norepinephrine sudden cardiac death ventricular fibrillation

项目摘要

项目成果

L FANANAPAZIR的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是探讨可逆性左旋的影响
英文摘要
The purpose of this study is to investigate the effects of reversible left stellate ganglion blockade on cardiac electrical activity, myocardial blood flow and norepinephrine kinetics in a selected group of symptomatic patients with hypertrophic cardiomyopathy (IHSS) who are shown to have inducible malignant ventricular arrhythmias during electrophysiologic studies and who are at high risk of sudden cardiac death. Presently we are awaiting the first patient.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INHERITED CARDIAC DISEASES--HYPERTROPHIC CARDIOMYOPATHY
CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
PREDICTION OF ADVERSE EFFECTS OF AMIODARONE BY SIGNAL AVERAGING IN HCM PATIENTS
INDUCTION OF MALIGNANT VENTRICULAR TACHYCARDIA ON AMIODARONE IN HCM PATIENTS
海外基金